TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/6/25 16:06 | 1/3/25 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | M.d | 82 | 9.00 | 0 | 9 | 2 | 461 | D | |||||||||||||||
11/20/24 16:30 | 11/19/24 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | M.d | 198 | 5.94 | 0 | 33 | 8 | 452 | D | |||||||||||||||
5/29/24 20:11 | 5/28/24 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | S.m | -789 | 75.17 | 0 | -10 | -42 | 15 | D | |||||||||||||||
9/15/23 18:30 | 9/15/23 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | M.d | 40 | 3.67 | 0 | 11 | 3 | 429 | M | |||||||||||||||
9/15/23 18:30 | 9/15/23 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | S.d | -2,224 | 75.18 | 0 | -30 | -6 | 429 | M | |||||||||||||||
1/4/23 16:11 | 1/3/23 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | M.d | 23 | 1.30 | 0 | 18 | 4 | 448 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |